欢迎来到创赛优选商城 !
Cy3-UTP(10mM) 抑胃肽酶液 PERFEMIKER AuroraGel 标准型基质胶,不含LDEV
光引发剂LAP 人工胃液 1%柠檬酸钠缓冲液 Salkowskis比色液 人工脑脊液(aCSF,无菌)
简介:甲磺酸去铁胺,Deferoxamine mesylate是一种铁螯合剂,可将游离铁与稳定的复合物结合,防止其发生化学反应。
甲磺酸去铁胺物理化学性质:
沸点
966.9ºC at 760 mmHg
熔点
148-149°
分子式
C26H52N6O11S
分子量
752.895
闪点
538.5ºC
精确质量
752.32959
PSA
268.59
LogP
2.989
外观性状
白色至灰白色粉末
蒸汽压
0mmHg at 25°C
储存条件
2~10℃保存
水溶解性
H2O: 50 mg/mL
甲磺酸去铁胺详细介绍:
中文名称:
甲磺酸去铁胺
中文别名:
甲磺酸去铁胺;甲磺酸去铁敏;甲磺酸除铁灵;甲磺酸去铁胺标准品;甲磺酸去铁胺标准品(JP);去铁铵;去铁铵 USP标准品;去铁胺甲磺酸盐 EP标准品;去铁胺甲磺酸酯;十一酸甘油三酯;云铁胺甲磺酸酯;DEFEROX胺甲磺酸盐;去铁胺甲磺酸盐;去铁铵/去铁敏
英文名称:
Deferoxamine mesylate
英文别名:
Deferoxamine mesylate;Deferoxamine mesylate salt;Deferoxamine (mesylate);EHNA;Deferoxamine Methanesulfonate;Desferrioxamine B mesylate;DFOM;DFOM,Deferoxamine methanesulfonate salt,Desferrioxamine mesylate salt;Deferoxamine methanesulfonate salt;Desferrioxamine mesylate salt;desferal;Prestwick_988;desferalmesylate;deferoxaminemesilate;deferoxaminebmesylate;DEFEROXAMINE MESYLATE;monomethanesulfonate(sa;desferrioxaminebmesylate;desferalmethanesulfonate
CAS号:
138-14-7
分子式:
C27H56N6O14S2
分子量:
752.90
详细描述:
创赛优选提供138-14-7,甲磺酸去铁胺,Deferoxamine mesylate,Medlife,上海现货。
Medlife,致力于提供高品质、高性价比小分子化合物的产品。
Medlife小分子化合物大量库存,提供超过2万种的抑制剂、激动剂、拮抗剂等产品,是药物及疾病研究的重要原料供应商。
铁螯合剂,Deferoxamine mesylate是一种铁螯合剂,可将游离铁与稳定的复合物结合,防止其发生化学反应。
查询关键词:“138-14-7,甲磺酸去铁胺,Deferoxamine mesylate,PC15129,Medlife,上海现货”。
甲磺酸去铁胺参考文献:
[1]. Li Y, et al. Effects of deferoxamine on blood-brain barrier disruption after subarachnoid hemorrhage. PLoS One. 2017 Mar 1;12(3):e0172784
[2]. Duscher D, et al. Comparison of the Hydroxylase Inhibitor Dimethyloxalylglycine and the Iron Chelator Deferoxamine in Diabetic and Aged Wound Healing. Plast Reconstr Surg. 2017 Mar;139(3):695e-706e
[3]. Wang G, et al. In vitro assessment of deferoxamine on mesenchymal stromal cells from tumor and bone marrow. Environ Toxicol Pharmacol. 2017 Jan;49:58-64
[4]. Wahl EA, et al. VEGF released by deferoxamine preconditioned mesenchymal stem cells seeded on collagen-GAG substrates enhances neovascularization. Sci Rep. 2016 Nov 10;6:36879
[5]. Fine JM, et al. Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation. Neurosci Lett. 2015 Jan 1;584:362-7
创赛客服1
创赛客服2
创赛客服3
创赛客服4
400-608-7598